![Alan I. Annex](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alan I. Annex
Directeur/Membre du Conseil chez Merand Pharmaceuticals, Inc.
Postes actifs de Alan I. Annex
Sociétés | Poste | Début | Fin |
---|---|---|---|
Merand Pharmaceuticals, Inc.
![]() Merand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merand Pharmaceuticals, Inc. engages in the provision of therapeutic products. It is developing a novel microRNA therapeutic (MicroRNA93 or miR-93) to treat patients suffering from Peripheral Arterial Disease (PAD). The company was founded in 2018 and is headquartered in Charlottesville, VA. | Directeur/Membre du Conseil | - | - |
Secrétaire Général | - | - |
Historique de carrière de Alan I. Annex
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 1 |
Corporate Secretary | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Merand Pharmaceuticals, Inc.
![]() Merand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merand Pharmaceuticals, Inc. engages in the provision of therapeutic products. It is developing a novel microRNA therapeutic (MicroRNA93 or miR-93) to treat patients suffering from Peripheral Arterial Disease (PAD). The company was founded in 2018 and is headquartered in Charlottesville, VA. | Health Technology |
- Bourse
- Insiders
- Alan I. Annex
- Expérience